1. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Issue 1 (December 2017) Authors: Sade-Feldman, Moshe; Jiao, Yunxin; Chen, Jonathan; Rooney, Michael; Barzily-Rokni, Michal; Eliane, Jean-Pierre; Bjorgaard, Stacey; Hammond, Marc; Vitzthum, Hans; Blackmon, Shauna; Frederick, Dennie; Hazar-Rethinam, Mehlika; Nadres, Brandon; Seventer, Emily; Shukla, Sachet; Yizhak, Keren; Ray, Joh... Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genome‐wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy. Issue 3 (12th March 2019) Authors: Sahu, Avinash Das; S Lee, Joo; Wang, Zhiyong; Zhang, Gao; Iglesias‐Bartolome, Ramiro; Tian, Tian; Wei, Zhi; Miao, Benchun; Nair, Nishanth Ulhas; Ponomarova, Olga; Friedman, Adam A; Amzallag, Arnaud; Moll, Tabea; Kasumova, Gyulnara; Greninger, Patricia; Egan, Regina K; Damon, Leah J; Frederick, De... Journal: Molecular systems biology Issue: Volume 15:Issue 3(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CMET-16. THE ROLE OF SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE IMMUNOTHERAPY ERA. (5th November 2018) Authors: Alvarez-Breckenridge, Christopher; Giobbie-Hurder, Anita; Gill, Corey; Bertalan, Mia; Stocking, Jackson; Kaplan, Alexander; Nayyar, Naema; Lawrence, Donald; Flaherty, Keith; Shih, Helen; Oh, Kevin; Batchelor, Tracy; Cahill, Daniel; Sullivan, Ryan; Brastianos, Priscilla Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Publisher Correction: Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. (December 2018) Authors: Auslander, Noam; Zhang, Gao; Lee, Joo; Frederick, Dennie; Miao, Benchun; Moll, Tabea; Tian, Tian; Wei, Zhi; Madan, Sanna; Sullivan, Ryan; Boland, Genevieve; Flaherty, Keith; Herlyn, Meenhard; Ruppin, Eytan Journal: Nature medicine Issue: Volume 24:Number 12(2018) Page Start: 1942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial. Issue 3 (March 2020) Authors: Dummer, Reinhard; Brase, Jan C; Garrett, James; Campbell, Catarina D; Gasal, Eduard; Squires, Matthew; Gusenleitner, Daniel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Flaherty, Keith; Larkin, James; Robert, Caroline; Kefford, Richard; Kirkwood, John M; Hauschil... Journal: Lancet oncology Issue: Volume 21:Issue 3(2020) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CMET-33. PHASE II STUDY OF PALBOCICLIB IN BRAIN METASTASES HARBORING CDK PATHWAY ALTERATIONS. (11th November 2019) Authors: Brastianos, Priscilla; Cohen, Justine; Wang, Nancy; Lee, Eudocia; Ligibel, Jennifer; Chukwueke, Ugonma; Keeley, Maura; Oh, Kevin; White, Michael; Gerstner, Elizabeth; Batchelor, Tracy; Lawrence, Donald; Ryan, David P; John Iafrate, A; Giobbie-Hurder, Anita; Flaherty, Keith; Santagata, Sandro; Car... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab‐Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results. (4th December 2017) Authors: O'Reilly, Eileen M.; Roach, James; Miller, Paul; Yu, Kenneth H.; Tjan, Catherine; Rosano, Molly; Krause, Silva; Avery, William; Wolf, Julie; Flaherty, Keith; Nix, Darrell; Ryan, David P. Journal: Oncologist Issue: Volume 22:Number 12(2017) Page Start: 1429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 228 Radiological dynamics and resistance types in patients with advanced melanoma treated with anti-PD-1 monotherapy. (9th November 2020) Authors: Bai, Xue; Kim, Michelle; Kasumova, Gyulnara; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Cohen, Justine; Lawrence, Donald; Freedman, Christine; Fadden, Riley; Rubin, Krista; Sharova, Tatyana; Frederick, Dennie; Flaherty, Keith; Sullivan, Ryan; Guo, Jun; Boland, Genevieve Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 228 Radiological dynamics and resistance types in patients with advanced melanoma treated with anti-PD-1 monotherapy. (9th November 2020) Authors: Bai, Xue; Kim, Michelle; Kasumova, Gyulnara; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Cohen, Justine; Lawrence, Donald; Freedman, Christine; Fadden, Riley; Rubin, Krista; Sharova, Tatyana; Frederick, Dennie; Flaherty, Keith; Sullivan, Ryan; Guo, Jun; Boland, Genevieve Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3. (4th November 2015) Authors: Powderly, John; Cote, Gregory; Flaherty, Keith; Szmulewitz, Russell Z; Ribas, Antoni; Weber, Jeffrey; Loo, Deryk; Baughman, Jan; Chen, Francine; Moore, Paul; Bonvini, Ezio; Vasselli, James; Wigginton, Jon; Cohen, Roger; Burris, Howard; Chmielowski, Bartosz Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗